• Orchard Therapeutics Appoints Jon Ellis to Board of Directors b3cnewswire
    August 06, 2018
    Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the appointment of Jon Ellis, Ph.D. as GSK’s designated representative t
PharmaSources Customer Service